Skip to content
Search

Latest Stories

Bolton locum pharmacist receives three-month suspension for workplace sexual misconduct

The Fitness-to-Practise Committee of the General Pharmaceutical Council has issued a three-month suspension to Mohammed Roohul Haque (Reg No: 2226084), a locum pharmacist, due to incidents of workplace sexual misconduct.

According to the determination document issued by the regulatory body, Haque undertook the position of a locum pharmacist at Hollowood Chemists on July 12. It was during this period that he encountered the dispenser (referred to as the "complainant"), a 40-year-old co-worker at the pharmacy, for the first instance. Following this initial meeting, he proceeded to engage in making explicit sexual comments.


During the lunch break of the pharmacy's second dispenser, Haque asked the dispenser, who had lodged the complaint, to review photographs displayed on his mobile phone, depicting renovations being carried out at his residence. The initial images focused on the ongoing renovation activities. However, he later switched to displaying a full-screen photograph of his erect penis, the document said.

Despite the fact that the dispenser promptly distanced herself, Haque persisted in discussing the photograph with her. He went so far as to apologise, and even asked if she had managed to closely observe the picture.

On the following day, July 13, 2021, the dispenser filed a formal complaint regarding Haque's misconduct with Hollowood's superintendent pharmacist. She also indicated her intention to report the incident to the General Pharmaceutical Council (GPhC), as mentioned in the document.

The case hearing took place from July 24 to 26.

Haque conceded to displaying a photograph of his erect penis to the dispenser, along with making remarks concerning her physical appearance. He acknowledged that his actions were inappropriate. However, he labelled the comments as banter and contended that he had unintentionally accessed the explicit picture, as detailed in the document.

The Committee, however, found Haque's explanation less convincing given the case's facts. He stated his comments were aimed at establishing a positive working relationship, but this contradicted evidence that he spent most of the morning on his mobile phone rather than assisting in the dispensary, as noted by the Committee.

It also took into consideration the Council's publication "Good decision-making" (revised March 2017) to understand the concept of 'fitness to practise’. Paragraph 2.11 reads: “A pharmacy professional is ‘fit to practise’ when they have the skills, knowledge, character, behaviour and health needed to work as a pharmacist…safely and effectively. In practical terms, this means maintaining appropriate standards of competence, demonstrating good character, and also adhering to the principles of good practice set out in your various standards, guidance and advice.”

The Committee reached the conclusion that Haque had intentionally displayed the image with the aim of seeking sexual satisfaction or pursuing a sexual connection. It further stated that he had misused his professional status, given that the individual impacted by his misconduct was a subordinate.

It further noted that Haque's misconduct was tempered by the fact that it occurred on a single day and did not involve any physical contact. As outlined in its decision, this placed the sexual misconduct at the less severe end of the spectrum.

The Committee found the allegations amounted to misconduct and chose to suspend Haque from the registry for three months, as detailed in the document. It also noted that a brief suspension period sufficed to signify the gravity of the registrant's inappropriate sexual behaviour, given his authentic understanding, remorse, and meaningful actions taken to address the matter.

Meanwhile, a noticeable shift in community pharmacy work patterns is occurring, with a greater reliance on locum pharmacists in the staffing model, according to 2022 Community Pharmacy Workforce Survey by NHS England. While employed pharmacists decreased by 16 per cent from 12,774 in 2021 to 10,943 in 2022, locum pharmacists increased by 26 per cent from 4,297 in 2021 to 5,477 in 2022. This trend persists even though locum pharmacists, on average, work fewer hours.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less